Campbell Alliance is the leading management consulting firm specializing in the pharmaceutical and biotech industry. When decision makers need assistance with major business challenges, they rely on us—a true strategic partner focused on their industry and their needs.
Feature Articles
From Troubles to Transformation - Pharmaceutical Executive
John Campbell, CEO of Campbell Alliance, discusses how today's challenging environment will hasten change in the working relationships between consulting firms and their pharma and biotech clients....
John Campbell, CEO of Campbell Alliance, discusses how today's challenging environment will hasten change in the working relationships between consulting firms and their pharma and biotech clients....
Optimizing the Impact of the Medical Affairs Function
To assess the evolving role of Medical Affairs and evaluate current organizational structures, responsibilities, and communication with Marketing, Campbell Alliance conducted primary research to learn how organizations have reacted to their changing environments. Our findings and analysis are included in this article....
To assess the evolving role of Medical Affairs and evaluate current organizational structures, responsibilities, and communication with Marketing, Campbell Alliance conducted primary research to learn how organizations have reacted to their changing environments. Our findings and analysis are included in this article....
REMS: The New Reality
This article highlights the challenges of new regulatory restrictions, lists potential competitive advantages to these programs, and describes how organizations need to adjust to the evolving risk mitigation landscape....
This article highlights the challenges of new regulatory restrictions, lists potential competitive advantages to these programs, and describes how organizations need to adjust to the evolving risk mitigation landscape....
The Valuation High Ground - Nature Biotech
Ben Bonifant, Vice President and Practice Area Leader, and Jeff Stewart, Senior Consultant, both of the Business Development Practice, outline a means of establishing and defending a rock-solid valuation....
Ben Bonifant, Vice President and Practice Area Leader, and Jeff Stewart, Senior Consultant, both of the Business Development Practice, outline a means of establishing and defending a rock-solid valuation....
Bracing for Biosimilars
This article examines the current movement toward an abbreviated approval pathway for follow-on biologics in the US and assesses the potential impact on current biotechnology products. ...
This article examines the current movement toward an abbreviated approval pathway for follow-on biologics in the US and assesses the potential impact on current biotechnology products. ...
The Ongoing Hopes and Challenges of Cancer Vaccines - Oncology Business Review
This article provides an overview of the current market for cancer vaccines as well as the development and commercialization challenges of advancing a product to market in the competitive landscape of anti-cancer immunotherapies....
This article provides an overview of the current market for cancer vaccines as well as the development and commercialization challenges of advancing a product to market in the competitive landscape of anti-cancer immunotherapies....